entertainment -WSS

entertainment

author：focus 2025-08-26 02:48:26 - browse：47895

The Chamber of Commerce in downtown Washington, DC. — The U.S. Chamber of Commerce sued to stop a new Medicare drug price negotiation program from going into effect. Adobe

WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday over whether drugmakers have enough say in Medicare’s new drug price negotiation program, in the first oral arguments in a lawsuit challenging the new law.

The two sides debated two questions: whether the Chamber of Commerce would be sufficiently injured by the law to file a lawsuit, and whether the negotiation program was a violation of drugmakers’ due process rights.

The hearing was held in the U.S. District Court for the Southern District of Ohio, and Judge Michael Newman, a Trump nominee, presided. Newman didn’t ask any questions of the attorneys, so the hearing didn’t provide any hints about which way he might be leaning on the issues.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Idaho abortion case may prompt more restrictions in other states

WSS

The SUPPORT Act is critical to fighting the opioid crisis

Doulas covered by Medicaid under New York's new plan

Designating disabled people as health disparity population is crucial

Twill hunts for pharma partner to market its depression app

How I ended up pumping milk in a bathroom stall at JPM 2024

Biotech reporter’s notebook: A sunnier mood at JPM 2024

entertainment

entertainment

focus

Jerome Adams on the need for new antivirals for Covid

Flagship, Pfizer team up in deal worth up to $7 billion

Guidelines to prevent youth baseball injuries need more muscle

How I ended up pumping milk in a bathroom stall at JPM 2024

Trump demands the U.S. pay no more for drugs than other countries … again

ER docs worry over extreme heat as a 'mass casualty event'

The high cost of giving birth even with insurance

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

ChatGPT in medicine: STAT answers readers' burning questions

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Wikipedia

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

entertainment

leisure time

hotspot

knowledge